Investment firm LeBaronBrown Llc has acquired American International Chemical Inc (AIC), a distributor of ingredients for the pharmaceutical sector and other industries.
SRF Limited has unveiled plans for a second chloromethane plant just two months after India imposed anti-dumping tariffs on Chinese and Russian imports.
US production of chemicals for the drug industry fell in April according to data released days after renewed calls for permanent tax breaks to help American manufacturers compete globally.
The acquisition of Sigma-Aldrich by Merck KGaA could provide some opportunities for Johnson Matthey, the fine chemical company says as it reports a flat first half 2014/15.
Aesica has secured a Technology Strategy Board grant to fund a high-value chemical manufacturing process with the winning process set to improve the sustainability of an active pharmaceutical Ingredient (API).
Efforts to cut industrial energy bills in the UK's 2014 Budget have been welcomed by the Chemical Industries Association (CIA), a group whose members include drug and ingredient makers.
Patheon has merged with Royal DSM's pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world's second biggest CMO.
in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans for a $20m API plant for Omkar.
SOCMA CEO predicts reintroduction of rejected permanent R&D tax credit plan and urges Congress to act “sooner rather than later” to support US manufacturers.
Lanxess has signalled its intentions for the future by investing €35m ($43m) to expand its German Basic Chemicals business unit in a move that is set to make the firm one of Europe’s biggest active pharmaceutical ingredients (API) producers.
Active pharmaceutical ingredient (API) manufacturer Ash Stevens Inc has been accredited under an industry-backed scheme that certifies companies whose processes are environmentally sound and safe.
US company Ferro has said it will sell off its fine chemicals division to private equity firm Arsenal Capital Partners, which will rename the business as Novolyte Technologies, for $66m.
Two chemical company directors have been sentenced for not notifying authorities that their company produced a substance controlled under the Chemical Weapons Convention (CWC).
Active pharmaceutical ingredient specialist Calyx Chemicals and Pharmaceuticals is planning an acquisition within the next two years, probably in the US or Europe, according to chief executive Smitesh Shah.
Despite a decade-long build up, drugmakers are yet to wake up to the “no data, no market” mantra of the EC’s REACH legislation, according to SAFC’s marketing director Amanda Halford.
A delegation from the Scotland's chemicals industry descended on
the recent Informex trade show in New Orleans, determined to
convince the assembled industry representatives that the country
should be at the top of the list for...
US contract manufacturer Albemarle has announced it will move
operations of its pilot plant in Ohio to its recently acquired
manufacturing facility in Michigan.
Clariant has cut its ties with the life sciences industry and will
no longer offer custom manufacturing services in this arena after
the sale of the last piece of its Lifesciences division.
One of the most influential medical journals, The Lancet,
has weighed into the European REACH chemicals debate, which is at
near boiling point as the draft legislation approaches its final
approval date in December.
Service provider Saltigo is reinforcing its position in the
stabilising fine chemical custom manufacturing industry by
investing in the expansion of its German facility.
The stage is ready for the biggest acquisition in BASF's 140-year
history after Engelhard's management agreed to recommend their
shareholders accept the German chemical group's $5bn (€3.8bn)
takeover bid.
Chemicals and nutrition group DSM has reported strong profits for
the first quarter in 2006, including in its pharma business, as
higher prices and lower costs have helped it overcome the increase
in raw material costs.
SAFC, a member of the Sigma-Aldrich Group, has launched a supply
solutions business, which aims to combine its Specialties business
with the manufacturing site that was acquired from Degussa last
year. The move is the latest step...
The break up of global fine and specialty chemicals company Avecia
continued as Fujifilm said it would take over Avecia Inkjet
formally next month. The €220 million fee to acquire the company's
Inkjet and Electrophotography...
Fine chemical and pharmaceutical intermediate manufacturers may be
affected by supply disruptions due to ongoing UK shortages of
natural gas. Price spikes in gas are becoming both higher and more
frequent in the UK.
A Strategic Research Agenda (SRA) was launched last week in a move
to bolster the chemistry and biotechnology industry's contribution
to European growth and competitiveness.
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.
KemFine, the fine chemicals business created via a management
buyout from chemicals group Kemira last year, has acquired Avecia
Fine Chemicals' business based in Grangemouth, Scotland.
The rapporteur trying to finesse the controversial REACH
legislation through the European Parliament, Guido Sacconi, has
formulated a compromise that aims to alleviate fears that the
regulations could pose a heavy financial burden...
Lanxess is to transform its fine chemicals business out into a
legally-discrete subsidiary as part of a programme to increase its
competitiveness in the market for pharmaceutical and agricultural
chemicals, reports Phil Taylor.
Germany's chemical companies have reported improved sales and
earnings in the first quarter of the year, and are optimistic of an
improved operating environment through 2005, reports Phil
Taylor.
The European Chemical Industry Council (CEFIC) has set up a new
umbrella group to represent the fine chemicals industry and provide
forum to tackle the volatile environment facing the sector.
German chemical and pharmaceutical company Merck KGaA has sold off
a manufacturing facility in France in a move aimed at consolidating
its global production infrastructure.
A study performed at Tufts University in the US, commissioned by
the Nordic Council of Ministers, has downplayed the impact of the
controversial REACH legislation on the European chemicals industry.
LGC, the independent analytical laboratory, has set up an
initiative alongside the UK Chemical Industries Association (CIA)
to advise chemical companies how to handle the new REACH
legislation.
Germany's mg technologies has completed the sale of Dynamit Nobel's
five business units on schedule at the end of July, marking its
exit from the fine chemicals and ingredients sector.
Lanxess, the fine chemicals unit that is due to be spun out of
Germany's Bayer next year, will be headed by Axel Westerhaus,
currently in charge of the group's polyethers business in the US.
German chemical company Bayer has posted flat first-quarter 2004
sales, but said that the results were on track given the negative
effects of currency factors. Organic sales growth rose 8.6 per
cent, it claimed, and was driven mainly...
Germany's MG technologies has agreed to sell the bulk of its
Dynamit Nobel chemicals division, sealing the fate of a company
that has been on the block since last November, writes Phil
Taylor.
Compared with European and US chemical companies, most domestic
Chinese chemical enterprises have remained technologically
challenged with productivity lagging behind international levels.
Germany chemical and pharmaceutical company Bayer has christened
its chemicals spin-off Lanxess, and says it is on schedule for a
stock market flotation early next year.
